Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ignace Vergote

Showing results (91-100 of 578) with videos related to

Pageof 58
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 10, 2007
Management of borderline ovarian neoplasmsIsabelle Cadron, Karin Leunen, Toon Van Gorp, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|August 6, 2010
The role of diaphragmatic surgery during interval debulking after neoadjuvant chemotherapy: an analysis of 74 patients with advanced epithelial ovarian cancerDimitris Tsolakidis, Frederic Amant, Toon Van Gorp, et al.
European Journal of Cancer (Oxford, England : 1990)|January 27, 2009
A randomised, double-blind, phase II study of two doses of pemetrexed in the treatment of platinum-resistant, epithelial ovarian or primary peritoneal cancerIgnace Vergote, Hilary Calvert, Marek Kania, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|February 7, 2009
Gynecologic Cancer Intergroup (GCIG) proposals for changes of the current FIGO staging systemEdgar Petru, Hans-Joachim Lück, Gavin Stuart, et al.
Gynecologic Oncology|March 22, 2003
Endometrial stromal sarcoma with a sole t(X;17) chromosome change: report of a case and review of the literatureFrédéric Amant, Philippe Moerman, Isabelle Cadron, et al.
European Journal of Cancer (Oxford, England : 1990)|September 28, 2011
Primary surgery or neoadjuvant chemotherapy followed by interval debulking surgery in advanced ovarian cancerIgnace Vergote, Frédéric Amant, Gunnar Kristensen, et al.
Gynecologic Oncology|June 9, 2015
Neoadjuvant chemotherapy followed by large cone resection as fertility-sparing therapy in stage IB cervical cancerRawand Salihi, Karin Leunen, Erik Van Limbergen, et al.
Gynecologic Oncology|September 7, 2007
Chemotherapy for recurrent cervical cancerIsabelle Cadron, Toon Van Gorp, Frederic Amant, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|August 5, 2016
Use of PlasmaJet for Peritoneal Carcinomatosis in Ovarian CancerEnrico Panuccio, Karin Leunen, Els Van Nieuwenhuysen, et al.
The Breast Journal|September 9, 2006
Aromatase inhibitors in premenopausal women: the need for proper contraceptive counselingIngrid Vandenput, Ignace Vergote, Frederic Amant, et al.
Pageof 58

Showing results (91-100 of 578) with videos related to

Sort By:
Pageof 58
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 10, 2007
Management of borderline ovarian neoplasmsIsabelle Cadron, Karin Leunen, Toon Van Gorp, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|August 6, 2010
The role of diaphragmatic surgery during interval debulking after neoadjuvant chemotherapy: an analysis of 74 patients with advanced epithelial ovarian cancerDimitris Tsolakidis, Frederic Amant, Toon Van Gorp, et al.
European Journal of Cancer (Oxford, England : 1990)|January 27, 2009
A randomised, double-blind, phase II study of two doses of pemetrexed in the treatment of platinum-resistant, epithelial ovarian or primary peritoneal cancerIgnace Vergote, Hilary Calvert, Marek Kania, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|February 7, 2009
Gynecologic Cancer Intergroup (GCIG) proposals for changes of the current FIGO staging systemEdgar Petru, Hans-Joachim Lück, Gavin Stuart, et al.
Gynecologic Oncology|March 22, 2003
Endometrial stromal sarcoma with a sole t(X;17) chromosome change: report of a case and review of the literatureFrédéric Amant, Philippe Moerman, Isabelle Cadron, et al.
European Journal of Cancer (Oxford, England : 1990)|September 28, 2011
Primary surgery or neoadjuvant chemotherapy followed by interval debulking surgery in advanced ovarian cancerIgnace Vergote, Frédéric Amant, Gunnar Kristensen, et al.
Gynecologic Oncology|June 9, 2015
Neoadjuvant chemotherapy followed by large cone resection as fertility-sparing therapy in stage IB cervical cancerRawand Salihi, Karin Leunen, Erik Van Limbergen, et al.
Gynecologic Oncology|September 7, 2007
Chemotherapy for recurrent cervical cancerIsabelle Cadron, Toon Van Gorp, Frederic Amant, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|August 5, 2016
Use of PlasmaJet for Peritoneal Carcinomatosis in Ovarian CancerEnrico Panuccio, Karin Leunen, Els Van Nieuwenhuysen, et al.
The Breast Journal|September 9, 2006
Aromatase inhibitors in premenopausal women: the need for proper contraceptive counselingIngrid Vandenput, Ignace Vergote, Frederic Amant, et al.
Pageof 58